Showing results (31-40 of 503) with videos related to
Sort By:
Pageof 51
Current Opinion in Pulmonary Medicine|July 13, 2015
Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosisChristopher S King, Steven D NathanSouthern Medical Journal|March 1, 1982
Prosthetic rehabilitation of extensive facial defectsB M Goldman, M D NathanCurrent Opinion in Gastroenterology|October 13, 2006
Neurohormonal control of pancreatic exocrine secretionJaimie D Nathan, Rodger A LiddleExpert Review of Anticancer Therapy|April 27, 2013
Vemurafenib in melanomaHeather M Shaw, Paul D NathanThe Mount Sinai Journal of Medicine, New York|January 27, 2009
Comorbidities of advanced lung diseaseJoel Anthony Nations, Steven D NathanFuture Oncology (London, England)|August 23, 2014
Role of the MEK inhibitor trametinib in the treatment of metastatic melanomaJudy W King, Paul D NathanActa Physiologica Polonica|March 1, 1989
Sialic acid at the surface of myocardial cells during embryonic developmentE K Cebrat, R D NathanCurrent Opinion in Pulmonary Medicine|August 4, 2017
Pitfalls in developing new compounds for idiopathic pulmonary fibrosisSteven D Nathan, Fernando J MartinezAnnals of the American Thoracic Society|September 22, 2017
The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary FibrosisA Whitney Brown, Steven D NathanThe Lancet. Respiratory Medicine|September 8, 2016
Idiopathic pulmonary fibrosis: effects and optimal management of comorbiditiesChristopher S King, Steven D NathanPageof 51